Serum-mediated blocking of cell-mediated anti-tumor immunity in a melanoma patient: association with BCG immunotherapy and clinical deterioration.

International journal of cancer ·Vol. 10 ·No. 2 ·1972-09-15 ·Pages 244-8

Levy NL, Mahaley MS, Day ED

Abstract

暂无摘要

MeSH Terms

Aged BCG Vaccine/adverse effects Brain Neoplasms/immunology Cytotoxicity Tests, Immunologic Fibroblasts/immunology Humans Immunity, Cellular/drug effects Lymphocytes/immunology Male Melanoma/drug therapy,immunology Neoplasm Metastasis Skin Neoplasms/drug therapy,immunology

Chemicals

BCG Vaccine

Authors & Affiliations

3 authors, click to expand affiliations / ORCID

Levy N L

Mahaley M S

Day E D

Article Info

Journal

International journal of cancer

Abbr.

Int J Cancer

ISSN

0020-7136

DOI

10.1002/ijc.2910100203

Published

1972-09-15

Pages

244-8

Language

English

Region

United States

NLM ID

0042124

Subset

External Links

PubMed source DOI: 10.1002/ijc.2910100203 View journal details

Analysis Services

Serum-mediated blocking of cell-mediated anti-tumor immunity in a melanoma patient: association with BCG immunotherapy and clinical deterioration.

Contact

WeChat Official Account